Gotham Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,508
| Closed | -$2.44M | – | 1764 |
|
|
2025
Q1 | $2.44M | Buy |
18,508
+7,501
| +68% | +$990K | 0.02% | 735 |
|
|
2024
Q4 | $919K | Buy |
11,007
+1,501
| +16% | +$125K | 0.01% | 947 |
|
|
2024
Q3 | $696K | Buy |
9,506
+4,220
| +80% | +$309K | 0.01% | 1010 |
|
|
2024
Q2 | $362K | Buy |
+5,286
| New | +$362K | ﹤0.01% | 1177 |
|
|
2017
Q1 | – | Sell |
-17,079
| Closed | -$258K | – | 1124 |
|
|
2016
Q4 | $258K | Buy |
+17,079
| New | +$258K | ﹤0.01% | 839 |
|